無料プレビュー

Abiomed, Inc. (ABMD) · NASDAQ Global Select

プロフィール

Abiomed, Inc. specializes in the creation and distribution of advanced medical technology designed to support or substitute the heart's pumping action in patients suffering from heart failure, while also offering ongoing care for these individuals. Its product portfolio includes various devices from the Impella family. The Impella 2.5 is a tiny percutaneous heart pump featuring an integrated motor and sensors, alongside the Impella CP, which is utilized by interventional cardiologists in catheterization labs and by cardiac surgeons during operations. Other Impella models such as the 5.0, LD, a

主要指標

株価: $381.02 (0.00%)
時価総額: 172億ドル
PER（今期予想）: —
PBR: 11.5
配当利回り: —
52週レンジ: $219.84 – $381.99
業種: Healthcare / Medical - Devices
上場: NASDAQ Global Select
構成銘柄: —

比較会社: ABT Abbott Laboratories、MDT Medtronic Plc、SYK Stryker Corporation、BSX Boston Scientific Corporation、EW Edwards Lifesciences Corporation、DXCM DexCom, Inc.、GEHC GE HealthCare Technologies Inc.、PHG Koninklijke Philips N.V.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2023-11-03 · 更新: 2026-10-09